Category: Oncology/Hematology
North America Oncology/Hematology
-
2024 Mexico Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Pipeline, Emerging Opportunities for Suppliers This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends ... Read More
-
Prostate Cancer Diagnostics
... by 2030, growing at a CAGR of 13.1% over the period 2023-2030. Preliminary Test, one of the segments analyzed in the report, is expected to record 12.4% CAGR and reach US$10 Billion by the end ... Read More
-
Cell Therapy Market, By Therapy Type (Stem Cells, T-cells, Dendritic Cells, NK-cells), By Indication (Oncology, Cardiology, Neurology, Others), By End User (Hospitals, Clinics, Research Institutes), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... East & Africa) Global cell therapy market is expected to witness growth substantially over the next decade due to rising prevalence of chronic diseases coupled with increasing geriatric population globally. Cell therapy is an emerging ... Read More
-
United States Liquid Biopsy Market Report by Cancer types (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, and Other Cancer), Products (Kits & Reagents, Platforms & Instruments, and Services), Application (Early Diagnosis, Patient Monitoring, and Recurrence Monitoring), Biomarkers (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA), Extracellular Vesicles (EVs), and Other Biomarker Types), Sample types (Blood, Urine, and Others), End-Users (Hospitals & Laboratories and Governments & Academic Research Centers), and Company Analysis 2024-2032
... Monitoring, and Recurrence Monitoring), Biomarkers (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA), Extracellular Vesicles (EVs), and Other Biomarker Types), Sample types (Blood, Urine, and Others), End-Users (Hospitals & Laboratories and Governments & Academic Research ... Read More
-
2023 North America Hematology Market Shares in the US, Canada and Mexico - Competitive Analysis of Leading and Emerging Market Players
... analyses current and emerging suppliers of hematology analyzers and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. The companies profiled in the report include: ... Read More
-
2024 Mexico Hematology and Flow Cytometry Database: Analyzers and Reagents, Supplier Shares, Test Volume and Sales Forecasts
... and flow cytometry tests, including: Hematology Tests CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils Flow Cytometry ... Read More
-
U.S. Cancer Contrast Media Market Size - By Product Type (Gadolinium-based Contrast Media, Iodinated Contrast Media), Modality (Nuclear Imaging, CT, MRI, Mammography), Application (Breast Cancer, Bladder Cancer, Lung Cancer), End-use & Forecast, 2024 - 2032
... U.S. Cancer Contrast Media Market size is poised to expand at 4.9% CAGR between 2024 and 2032 driven by the continuous technological advancements in imaging and the launch of new products. Innovations in MRI and ... Read More
-
North America Radiopharmaceutical Theranostics Market Forecast to 2028 - Regional Analysis - by Product Type [Alpha Emitters, Beta Emitters, and Positron Emission Tomography (PET) Tracers], Radioisotope [Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fluorine-18 (18F), Yttrium 90 (Y-90), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (CDx)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic and Research Institutes, and Others)
... Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (CDx)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic ... Read More
-
US Generic Drug Market Report by Segment (Unbranded, Branded), Therapy Area (CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), Drug Delivery (Oral, Injectables, Dermal/Topical, Inhalers), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) 2024-2032
... US generic drug market size reached US$ 90.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 124.3 Billion by 2032, exhibiting a growth rate (CAGR) of 3.5% during 2024-2032. The ... Read More
-
Non-muscle Invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middl
... and Africa) The global non-muscle invasive bladder cancer therapeutics market reached a valuation of US$ 2.8 billion in 2024. The market is forecasted to progress to reach US$ 9.2 billion by the end of 2031. ... Read More
-
2024 Global Clinical Chemistry and Immunodiagnostics Market in the US, Europe, Japan - 2023 Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Te
... TDM Tests This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), ... Read More
-
2024 North America Clinical Chemistry and Immunodiagnostics Market in the US, Canada and Mexico - 2023 Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein
... Immunoprotein and TDM Tests This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, ... Read More
-
2024 Canada Clinical Chemistry and Immunodiagnostics Market - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests
... provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood Urea Nitrogen), ... Read More
-
North America Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis - by Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral and Non-Viral Vector)], Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)]
... Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)] The North America cell and gene therapy manufacturing services market is expected to grow from US$ 4,153.27 ... Read More
-
North America Fluorescence In-Situ Hybridization (Fish) Imaging Systems Market Forecast to 2030 – Regional Analysis – By Product (Instruments, Consumables, Accessories, and Software), Application (Cancer Diagnosis, Genetic Disease Diagnosis, Infectious Disease Diagnostic, and Others), and End User (Diagnostic Laboratories, Contract Research Organizations, Pharmaceutical and Biotechnological Companies, and Others)
... End User (Diagnostic Laboratories, Contract Research Organizations, Pharmaceutical and Biotechnological Companies, and Others) The North America fluorescence in-situ hybridization (FISH) imaging systems market is expected to grow from US$ 507.0 million in 2022 to US$ ... Read More
-
Oncologists Global Market Opportunities And Strategies To 2032 Including: 1) By Cancer Diagnosis And Treatment: Cancer Diagnosis; Cancer Treatment 2) By Indication: Lungs Cancer; Colorectal Cancer; Breast Cancer; Liver Cancer; Bladder Cancer; Head And Neck Cancer; Prostate Cancer 3) By Service Provider: Hospitals; Diagnostic Laboratories; Diagnostic Imaging Centers; Specialty Clinics; Academia Covering: Kaiser Foundation Health Plan, Inc.; HCA Healthcare, Inc.; The University of Texas MD Anderson Cancer Center; Tenet Healthcare Corporation; Universal Health Services, Inc.
... Cancer3) By Service Provider: Hospitals; Diagnostic Laboratories; Diagnostic Imaging Centers; Specialty Clinics; AcademiaCovering: Kaiser Foundation Health Plan, Inc.; HCA Healthcare, Inc.; The University of Texas MD Anderson Cancer Center; Tenet Healthcare Corporation; Universal Health Services, ... Read More
-
Immuno-Oncology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... relentless global health challenge, is the second-leading cause of death worldwide, following cardiovascular disease. According to the World Health Organization (WHO), an estimated 8.3 million lives are claimed by cancer annually, with approximately 70% of ... Read More
-
North America Digital Thoracic Drainage Devices Market Forecast to 2030 - Regional Analysis - by Product Type (Single Chamber and Multiple Chambers), Application (Cardiac Surgery, Thoracic and Pulmonary Surgery, Oncology and Trauma, Infectious Diseases, and Others), and End User (Hospitals, Ambulatory Surgical Centers, and Others)
... Others), and End User (Hospitals, Ambulatory Surgical Centers, and Others) The North America digital thoracic drainage devices market is expected to grow from US$ 51.10 million in 2022 to US$ 77.70 million by 2030. It ... Read More
-
North America Radioactive Tracer Market Forecast to 2030 - Regional Analysis - by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others), and End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others)
... Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, ... Read More
-
NA Acute Myeloid Leukemia Diagnostics Market - Industry Trends and Forecast to 2035
... to 2031. The new market report contains data for the historic year 2022, the base year of calculation is 2023, and the forecast period is 2024 to 2031. Market Segmentation North America Acute Myeloid Leukemia ... Read More
-
Liquid Biopsy Market (4th Edition), 2018-2022 (Historical Trends) and 2023-2035 (Forecasted Estimates): Distribution by Application (Early Cancer Diagnosis, Patient Monitoring, Treatment Selection, Recurrence Monitoring and Others), Target Disease Indication (Bladder Cancer, Breast Cancer, Colorectal Cancer, Gastric Cancer, Lung Cancer, Prostate Cancer and Others), Type of Circulating Biomarker (Cell Free DNA, Cell Free RNA, Circulating Tumor DNA, Extracellular Vesicles and Others Circulating Biomarkers), Type of Sample (Blood / Plasma and Others), End users (Hospitals, Research Institutes and Others), Stage of Development (Launched and Under Development), Type of Product (Assay kits, Devices, Software/ Algorithms and others), Type of Technique (Polymerase Chain Reaction, Next Generation Sequencing and Others), Application Area ( Clinical use, Research use only) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecast
... Gastric Cancer, Lung Cancer, Prostate Cancer and Others), Type of Circulating Biomarker (Cell Free DNA, Cell Free RNA, Circulating Tumor DNA, Extracellular Vesicles and Others Circulating Biomarkers), Type of Sample (Blood / Plasma and Others), ... Read More
-
U.S. Prostate Cancer Nuclear Medicine Diagnostics Market Size, Share & Trends Analysis Report By Type (SPECT, PET), By PET Product (F-18, SR-82/RB-82), And Segment Forecasts, 2023 - 2030
... Growth & Trends The U.S. prostate cancer nuclear medicine diagnostics market size is expected to reach USD 153.97 million by 2030, according to a new report by Grand View Research, Inc. It is anticipated to ... Read More
-
Breast Cancer Screening Tests Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Africa) Breast cancer, a potentially life-threatening condition, can be detected early through screening tests, offering a higher chance of recovery. While breast cancer screening doesn't prevent the disease, it plays a crucial role in identifying ... Read More
-
Uterine Cancer Diagnostic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Africa) The uterus, a crucial female organ known as the womb, plays a vital role in supporting fetal development until birth. However, the specter of uterine cancer looms over many, with two distinct types: endometrial ... Read More
-
Triple Negative Breast Cancer Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... and Africa) The global revenue from the triple-negative breast cancer treatment market amounted to approximately US$ 680 million in 2024, and the market is poised to reach approximately US$ 900 million by the end of ... Read More
Research Assistance
